<DOC>
	<DOCNO>NCT01623700</DOCNO>
	<brief_summary>This observational study base Register Information Knowledge About Swedish Heart Intensive Care Admissions ( RIKS-HIA ) Swedish Coronary Angiography Angioplasty Registry ( SCAAR ) since 2009 merge The Swedish Web-system Enhancement Development Evidence-based care Heart disease Evaluated According Recommended Therapies ( SWEDEHEART ) . The aim study investigate impact different antithrombotic treatment option ( treatment duration , type treatment combination treatment ) Acute Coronary Syndrome ( ACS ) patient outcomes recurrent ischemic event mortality .</brief_summary>
	<brief_title>Outcome Longterm Antithrombotic Therapy Acute Coronary Syndrome Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<criteria>Patient event ACS study period Patient find National Registry Drug Prescriptions treat treat antithrombotic drug/s ( acetylsalicylic acid and/or either clopidogrel/ticlopidine/prasugrel and/or warfarin ) Patients exclude database fulfill inclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>clopidogrel</keyword>
	<keyword>aspirin</keyword>
	<keyword>percutaneous coronary intervention</keyword>
	<keyword>coronary stenting</keyword>
	<keyword>antiplatelet</keyword>
</DOC>